News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
722,160 Results
Type
Article (40954)
Company Profile (268)
Press Release (680928)
Multimedia
Podcasts (81)
Webinars (17)
Section
Business (204691)
Career Advice (2025)
Deals (35537)
Drug Delivery (111)
Drug Development (81397)
Employer Resources (173)
FDA (16423)
Job Trends (14948)
News (346438)
Policy (32732)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2569)
Accelerated approval (34)
Adcomms (24)
Allergies (143)
Alliances (49581)
ALS (170)
Alzheimer's disease (1675)
Antibody-drug conjugate (ADC) (314)
Approvals (16694)
Artificial intelligence (518)
Autoimmune disease (159)
Automation (41)
Bankruptcy (361)
Best Places to Work (11637)
BIOSECURE Act (20)
Biosimilars (192)
Biotechnology (174)
Bladder cancer (158)
Brain cancer (57)
Breast cancer (641)
Cancer (4836)
Cardiovascular disease (405)
Career advice (1710)
Career pathing (36)
CAR-T (283)
CDC (45)
Celiac Disease (2)
Cell therapy (748)
Cervical cancer (36)
Clinical research (69614)
Collaboration (1714)
Company closure (4)
Compensation (1172)
Complete response letters (57)
COVID-19 (2714)
CRISPR (93)
C-suite (860)
Cystic fibrosis (143)
Data (6272)
Decentralized trials (2)
Denatured (25)
Depression (137)
Diabetes (502)
Diagnostics (6703)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (254)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (233)
Earnings (90242)
Editorial (57)
Employer branding (21)
Employer resources (152)
Events (117376)
Executive appointments (980)
FDA (19561)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1478)
Gene editing (199)
Generative AI (43)
Gene therapy (597)
GLP-1 (967)
Government (4666)
Grass and pollen (6)
Guidances (384)
Healthcare (18879)
HIV (62)
Huntington's disease (45)
IgA nephropathy (83)
Immunology and inflammation (254)
Immuno-oncology (57)
Indications (116)
Infectious disease (2989)
Inflammatory bowel disease (191)
Inflation Reduction Act (14)
Influenza (119)
Intellectual property (254)
Interviews (316)
IPO (16643)
IRA (50)
Job creations (3644)
Job search strategy (1428)
JPM (57)
Kidney cancer (16)
Labor market (86)
Layoffs (548)
Leadership (32)
Legal (7951)
Liver cancer (91)
Longevity (14)
Lung cancer (654)
Lymphoma (379)
Machine learning (42)
Management (59)
Manufacturing (807)
MASH (164)
Medical device (13775)
Medtech (13830)
Mergers & acquisitions (19971)
Metabolic disorders (1272)
Multiple sclerosis (163)
NASH (16)
Neurodegenerative disease (321)
Neuropsychiatric disorders (88)
Neuroscience (2919)
Neurotech (1)
NextGen: Class of 2026 (6520)
Non-profit (4515)
Now hiring (68)
Obesity (598)
Opinion (262)
Ovarian cancer (167)
Pain (198)
Pancreatic cancer (229)
Parkinson's disease (282)
Partnered (33)
Patents (506)
Patient recruitment (495)
Peanut (56)
People (58906)
Pharmaceutical (63)
Pharmacy benefit managers (29)
Phase 1 (21697)
Phase 2 (30634)
Phase 3 (22831)
Pipeline (5401)
Policy (285)
Postmarket research (2564)
Preclinical (9202)
Press Release (64)
Prostate cancer (238)
Psychedelics (48)
Radiopharmaceuticals (283)
Rare diseases (844)
Real estate (5956)
Recruiting (70)
Regulatory (24532)
Reports (53)
Research institute (2390)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (80)
Schizophrenia (148)
Series A (241)
Series B (192)
Service/supplier (11)
Sickle cell disease (97)
Special edition (22)
Spinal muscular atrophy (157)
Sponsored (42)
Startups (3616)
State (2)
Stomach cancer (18)
Supply chain (105)
Tariffs (84)
The Weekly (54)
Vaccines (1012)
Venture capital (89)
Weight loss (381)
Women's health (92)
Worklife (18)
Date
Today (97)
Last 7 days (528)
Last 30 days (2281)
Last 365 days (29864)
2026 (3844)
2025 (30176)
2024 (35218)
2023 (40077)
2022 (51174)
2021 (55714)
2020 (54084)
2019 (46539)
2018 (35023)
2017 (32113)
2016 (31484)
2015 (37561)
2014 (31319)
2013 (26346)
2012 (28573)
2011 (29264)
2010 (27328)
Location
Africa (736)
Alabama (84)
Alaska (7)
Arizona (310)
Arkansas (13)
Asia (39242)
Australia (6414)
California (11364)
Canada (3311)
China (1103)
Colorado (479)
Connecticut (482)
Delaware (339)
Europe (84589)
Florida (1704)
Georgia (359)
Hawaii (3)
Idaho (61)
Illinois (868)
India (68)
Indiana (524)
Iowa (22)
Japan (434)
Kansas (127)
Kentucky (39)
Louisiana (26)
Maine (72)
Maryland (1391)
Massachusetts (8131)
Michigan (327)
Minnesota (631)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (78)
New Jersey (3018)
New Mexico (28)
New York (2999)
North Carolina (1465)
North Dakota (8)
Northern California (5558)
Ohio (335)
Oklahoma (21)
Oregon (41)
Pennsylvania (2298)
Puerto Rico (24)
Rhode Island (48)
South America (1108)
South Carolina (66)
South Dakota (1)
Southern California (4426)
Tennessee (177)
Texas (1750)
United States (40284)
Utah (337)
Vermont (1)
Virginia (264)
Washington D.C. (81)
Washington State (923)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
722,160 Results for "ppd inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Reunion Neuroscience Presents Full Data from RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD) at ACNP Annual Meeting
January 20, 2026
·
5 min read
Press Releases
Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer’s Disease Registry to Advance Real-World Evidence in Neurodegenerative Care
December 19, 2025
·
3 min read
Press Releases
Reunion Neuroscience Announces Positive Topline Results from RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD)
August 19, 2025
·
8 min read
Business
Medidata and Thermo Fisher Scientific’s PPD Clinical Research Business Collaborate to Accelerate Clinical Trials Innovation
Medidata today announced it has renewed its relationship with the PPD clinical research business of Thermo Fisher Scientific Inc.
February 28, 2024
·
3 min read
Press Releases
Reunion Neuroscience Announces Last Patient Dosed in RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD)
May 19, 2025
·
4 min read
Pharm Country
Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plus™, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM.
April 23, 2024
·
7 min read
Drug Development
Thermo Fisher Scientific’s PPD Clinical Research Business Selected by BARDA to Support Phase II Platform Clinical Trial to Treat Acute Respiratory Distress Syndrome (ARDS)
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, has been selected by the Biomedical Advanced Research and Development Authority (BARDA) to implement the first BARDA-supported Phase II platform clinical trial to investigate multiple therapeutic options for the treatment of acute respiratory distress syndrome (ARDS).
December 21, 2023
·
4 min read
Press Releases
BioSyent to Acquire Oral Science Inc.
February 9, 2026
·
10 min read
Press Releases
Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock
February 18, 2026
·
5 min read
Press Releases
Axogen, Inc. to Participate in Multiple Upcoming March 2026 Investor Conferences
February 17, 2026
·
1 min read
1 of 72,216
Next
